Predictmedix AI Inc C.PMED

Alternate Symbol(s): PMEDF

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.

CSE:PMED - Post by User

Predictmedix AI Inc > What Happened to Sales Contract?

<< Previous

Bullboard Posts

Next >>

Post by badog222on Feb 22, 2021 10:58am

194 Views

Post# 32626019

What Happened to Sales Contract?

Does anyone know what ever happened to the sales contract listed below? I have never seen any revenues reported by PMED period....let alone from what PMED called a significant sales contract with the following outfit.

July 7, 2020

Predictmedix announces its first significant UK sales contract

TORONTO, ON / ACCESSWIRE / July 7, 2020 / Predictmedix Inc. (PMED.CN)(PMEDF) ("Predictmedix" or the "Company") is pleased to announce the execution of a sales contract for its COVID-19 screening technology with Taurus Medical Solutions ("Taurus"), a medical distributor based out of the United Kingdom which is also a supplier to United Kingdom National Health Service "NHS".

July 7, 2020

Predictmedix announces its first significant UK sales contract

TORONTO, ON / ACCESSWIRE / July 7, 2020 / Predictmedix Inc. (PMED.CN)(PMEDF) ("Predictmedix" or the "Company") is pleased to announce the execution of a sales contract for its COVID-19 screening technology with Taurus Medical Solutions ("Taurus"), a medical distributor based out of the United Kingdom which is also a supplier to United Kingdom National Health Service "NHS". Furthermore, Predictmedix is also pleased to announce that it has filed two patent applications with the United States Patent and Trademark Office for its telehealth/telemedicine and remote patient monitoring platform.